DEAProposed Rule
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
HealthcareOther
Ad Space (leaderboard)
Summary
The Drug Enforcement Administration (DEA) is proposing to classify bromazolam, a dangerous synthetic drug, as a Schedule I controlled substance, which is the most restrictive category reserved for drugs with no medical use and high abuse potential. This means bromazolam would become illegal to manufacture, distribute, or possess without special permission, similar to heroin and LSD.
Key Points
- 1Bromazolam, a synthetic benzodiazepine-like drug sold on illegal markets, would be temporarily placed in Schedule I, making it federally illegal
- 2The drug is being restricted because it poses serious health risks including overdose, addiction, and dangerous interactions with other substances
- 3People caught with bromazolam could face criminal penalties including fines and prison time
- 4This is a proposed rule, meaning the DEA is seeking public feedback before making it final
- 5The temporary placement allows the DEA time to study the drug further while protecting public health immediately
Key Dates
Published
December 15, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)